ANTIDIABETIC POTENTIAL OF ALCOHOLIC AND AQUEOUS EXTRACTS OF FICUS RACEMOSA LINN. BARK IN NORMAL AND ALLOXAN INDUCED DIABETIC RATS
Abstract
The present investigation aims to examine the diabetic potential of the plant Ficus racemosa in normal and alloxan induced diabetic rats. The bark extract with water, petroleum ether and with alcohol were screened for blood glucose lowering activity and the alcoholic extract having better therapeutic potential was prepared through Soxhlet extraction for further study. Alcoholic and aqueous extract of bark of Ficus racemosa at a dose of 400 mg/Kg was given to normal and alloxan induced diabetic rats and the blood samples taken from the retero-orbital plexus vein were analyzed for blood glucose level as per standard protocol with available kits through Auto-analyzer. The comparison of blood sugar level as per model schedule showed that in normal group the ethanolic extract, at a dose of 400 mg/Kg intra-peritoneal, the blood glucose lowering 28.66 % while in aqueous extract given group it was 25.90 %. In alloxan induced diabetic rats decrease in blood glucose level in aqueous and ethanolic extract group was found to be 27.01 % and 45.03 % respectively. In conclusion, the ethanolic extract of Ficus racemosa reflected anti-diabetic potential through its glucose lowering activity in experimental animals. It supported the folklore claim of anti-diabetic activity of the plant.
Keywords:
Ficus Racemosa, Antidiabetic, herbal remedyDOI
https://doi.org/10.25004/IJPSDR.2009.010106References
2. Gautam, M.K. Effect of Murraya paniculata leaves on streptozotocin induced oxidative stress in diabetic rats. M.Pharm Thesis, India. Vinayaka Mission’s Research Foundation, Deemed University, Salem-636008, Tamilnadu; 2007 Mar. 3-5pp.
3. Barar, F.S.K. Essential of Pharmacotherapeutics, India, S. Chand and company LTD. Ram nagar, New Delhi. 2000 pp-340-344.
4. Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1988; 5:113-24.
5. Mukherjee, S.K., Saxena, A.M., Sukla, G. Progress of diabetes research in India during 20th century, India, National Institute of Science Communication (CSIR), Edn 1st, 2002. pp-1-3.
6. Tiinamaija Tuomi. Type I and Type II diabetes, Diabetes, 2005; 34: 3214-3218.
7. Puratchi Mani.V. Formulation, standardization and quality control of some antidiabetic herbal drugs, PhD thesis, BIT, Ranchi. India. 2003, pp 9-11.
8. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes care 1989; 12: 553-64.
9. Vaidyaratnam, P.S. Indian Medicinal Plants; A compendium of 500 species. Vol.3; India, Varier’s Arya Vaidya Sala, Kottakkal Publication: Orient Longman Coll. No. AVS 2308; 34-37pp.
10. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals, Pain. 1983; 16: 109-110.
11. Khandelwal KR. Practical Pharmacognosy technique and experiments. Edn 2ndPune, India, Nirali Prakashan, 2000; 149-56.
12. Kokate, C.K. Practical Pharmacognosy, India Vallabh Prakashan, Delhi. Edn 4th, 2005; 107-111pp.
13. Veeraraghavan P. Expert consultant CPCSEA, OECD guideline no.420.
14. Babu, V., Subramoniam, A. Antidiabetic activity of ethenol extract of Cassia kleinii leaf in streptozotocin-induced diabetic rats and isolation of an active fraction and toxicity evaluation of the extract. Ind J Pharmacol, 2003; 35: 290-296.
15. Ghosh, M.N. Fundamentals of experimental pharmacology, India. Scientific Book Agency, Calcutta, Edn 2nd, 1984, 153-159pp
16. Zimmet, P., Alberti, K., Shaw, J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
17. Furusho T., Kataoka E., Yasuhara T., wada M., Innami S., Administration of β-carotene suppresses lipidperoxidation in tissues and improves the glucose tolerance ability of streptozotocin induced diabetic rats. Int J. Vitam Nutr Res 2002; 72 (2): 71-76.
18. Gupta, D., Raju, J., Baquer, N.Z. Modulation of some gluconeogenic enzyme activities in diabetic rat liver and kidney: effect of antidiabetic compounds. Ind J ExpBio 1999; 37 (2): 196-199.
19. Gilon P, Ravier MA, Jonas JC, Henquin J.C. Control mechanisms of the oscillations of insulin secretion in vitro and in vivo. Diabetes 2002; 51 (Suppl. 1): S144_S151, 2002.
20. Westerlund J., Bergsten P. Glucose metabolism and pulsatile insulin release from isolated islets. Diabetes 2001; 50:1785–1790.
Published

